[go: up one dir, main page]

Revision history of "Phase 3, randomized, controlled trial of atrasentan in patients with nonmetastatic, hormone-refractory prostate cancer" (Q34898980)

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

11 July 2024

20 March 2023

19 June 2022

17 January 2022

24 September 2021

20 May 2021

15 April 2021

4 November 2019

30 September 2019

28 July 2019

7 April 2019

27 March 2019

  • curprev 16:2016:20, 27 March 2019 Emijrpbot talk contribs 64,000 bytes +4,742 Updated Item: BOT - Adding descriptions (56 languages): ast, bg, bn, ca, cs, da, de, el, eo, es, et, fa, fi, fr, gl, he, hu, hy, it, ja, ka, ko, lt, nan, nb, nn, oc, pl, pt, pt-br, ro, ru, sk, sq, sr, sr-ec, sr-el, sv, tg, tg-cyrl, th, tl, tr, ur, vi, wuu, yue, zh, zh-cn, zh-hans, zh-hant, zh-hk, zh-mo, zh-my, zh-sg, zh-tw undo (restore)

23 December 2018

6 December 2018

26 October 2018

10 September 2018

1 September 2018

8 July 2018

8 November 2017

2 November 2017

5 August 2017